🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07736976
Starting soon Observational

Comparison of 30-Second Sit-to-Stand Test Performance Between Individuals With Hemophilia and Healthy Peers

NCT07736976 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-08-01
Last updated
2026-07-31

Condition(s) studied

Hemophilia A and B

Study summary

Hemophilia is an inherited bleeding disorder characterized by recurrent musculoskeletal bleeding, particularly into joints, leading to impaired physical function and reduced functional performance. The 30-Second Sit-to-Stand Test (30STS) is a simple, reliable, and valid measure of lower extremity functional performance; however, evidence regarding its performance in individuals with hemophilia remains limited. This cross-sectional observational study aims to compare 30STS performance between adults with hemophilia and age-matched healthy controls and to investigate the relationship between 30STS performance, joint health, and activity level in individuals with hemophilia. Fifty-eight participants (29 individuals with hemophilia and 29 healthy controls) aged 18-35 years will be recruited. Participants will complete the 30STS. Individuals with hemophilia will additionally undergo joint health assessment using the Hemophilia Joint Health Score (HJHS) and activity evaluation using the Hemophilia Activities List (HAL).

Eligibility

Sex
MALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria: Hemophilia Group: * Diagnosis of hemophilia A or hemophilia B * Age between 18 and 35 years * Ability to walk independently * Willingness to participate in the study voluntarily Healthy Control Group: * Age between 18 and 35 years * No history of hemophilia or other bleeding disorders * No history of lower extremity surgery or serious lower extremity injury within the previous 6 months * No neurological, rheumatological, or severe orthopedic disorders * Willingness to participate in the study voluntarily Exclusion Criteria: Hemophilia Group: \- Acute joint bleeding episode within the previous 3 months

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Bahcesehir university Istanbul Istanbul

More Bahçeşehir University trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07736976 on ClinicalTrials.gov ↗ ← All trials in Turkey